Successful report of reduced-intensity stem cell transplantation from unrelated umbilical cord blood in a girl with chronic active Epstein-Barr virus infection

J Pediatr Hematol Oncol. 2006 Apr;28(4):254-6. doi: 10.1097/01.mph.0000212916.29889.c2.

Abstract

We describe an 8-year-old girl with chronic active Epstein-Barr virus (EBV) infection (CAEBV) who was treated successfully by reduced-intensity stem cell transplantation (RIST) from unrelated cord blood (CB). She had been suffering from fever, abdominal pain, and interstitial lymphadenopathy, and CAEBV was diagnosed. After chemotherapy that included etoposide, the amount of EBV decreased transiently below the detection level. However, the disease due to CAEBV worsened despite the chemotherapy, and she finally needed chemotherapy every week. Therefore, instead of conventional myeloablative transplantation, we performed CB transplantation with reduced-intensity conditioning regimens consisting of low-dose total body irradiation, fludarabine, and etoposide. CB, for which human leukocyte antigen (HLA) was 2-loci mismatched on the DR loci from an unrelated donor, was infused after conditioning. Although grade III acute graft-versus-host disease (GVHD) in the gut and chronic GVHD in the lung developed, the symptoms of GVHD disappeared with immunosuppressive therapy. After 15 months, the patient remained a complete chimera, with undetectable levels of EBV in peripheral blood and bone marrow. We conclude that RIST from unrelated CB can be indicated for some cases of CAEBV who are refractory to chemotherapy and have no HLA-matched related and unrelated donors as the source of bone marrow or peripheral blood stem cells.

Publication types

  • Case Reports

MeSH terms

  • Blood Transfusion*
  • Bone Marrow / virology
  • Child
  • Epstein-Barr Virus Infections / blood
  • Epstein-Barr Virus Infections / therapy*
  • Female
  • Fetal Blood*
  • Herpesvirus 4, Human / isolation & purification
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Stem Cell Transplantation / methods*
  • Transplantation Chimera
  • Treatment Outcome

Substances

  • Immunosuppressive Agents